Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 225.74B, Merck(MRK) trades at $91.09. The stock has a price-to-earnings ratio of 11.48 and currently yields dividends of 3.7%.
As of 2025-11-12, Merck(MRK) stock has fluctuated between $86.81 and $91.19. The current price stands at $91.09, placing the stock +4.9% above today's low and -0.1% off the high.
The Merck(MRK)'s current trading volume is 15.44M, compared to an average daily volume of 11.97M.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
During the past year, Merck(MRK) stock moved between $73.31 at its lowest and $105.07 at its peak.
MRK News
In recent days, Merck shared initial Phase 3 results showing its investigational once-daily oral PCSK9 inhibitor, enlicitide decanoate, led to substantial and s...
The Dow Jones Industrial Average finished on Tuesday with its 16th record close of the year. The Dow Jones Industrial Average ended Tuesday’s session at an all...
As the U.S. stock market shows signs of optimism with major indexes rebounding on hopes for a resolution to the government shutdown, investors are keenly observ...
Analyst ratings
57%
of 28 ratingsMore MRK News
Merck (MRK), known as MSD outside of the United States and Canada, announced the first presentation of results from the Phase 3 CORALreef HeFH trial demonstrati...
(RTTNews) - Merck & Co Inc. (MRK) has unveiled the first results from its pivotal Phase 3 CORALreef Lipids trial, highlighting the efficacy of enlicitide decano...
Merck (MRK) said Saturday its new pill — a potential rival to injections from Regeneron Pharmaceuticals (REGN) and Amgen (AMGN) — lowered stubbornly high choles...
Merck (MRK) shares are starting the week with a modest uptick, trading higher after recent volatility. Some investors are keeping an eye on the company’s longer...
Insiders have been trading these 5 stocks: ((JPM)), ((ADBE)), ((LLY)), ((MCD)) and ((MRK)). Here is a breakdown of their recent trades and their value. Meet Yo...
Wondering if Merck is trading below its true worth, or if the market is missing something? You are not alone, and digging deeper can reveal some surprising valu...